Frank Grünebach

5.3k citations

73 papers · 4.2k indexed · h-index 38

Impact in

Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Hematology top 1%

Papers in

Immunology 55
- Immunotherapy and Immune Responses 44
- Immune Cell Function and Interaction 23
- T-cell and B-cell Immunology 21
- Immune Response and Inflammation 10
Hematology 14
- Chronic Myeloid Leukemia Treatments 9

Co-authors: Peter Brossart Lothar Kanz Alessio Nencioni Markus M. Weck Wolfram Brugger Martin Müller Silke Appel Alberto Ballestrero
Journals: Blood (21 papers)Clinical Cancer Research (5 papers)Leukemia (4 papers)The Journal of Immunology (4 papers)Cancer Immunology Immunotherapy (4 papers)
Partner nations: Germany United States Italy

In The Last Decade

Frank Grünebach

71 papers receiving 4.2k citations

Peers

Countries citing papers authored by Frank Grünebach

Since Specialization

Citations

This map shows the geographic impact of Frank Grünebach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Grünebach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Grünebach more than expected).

Fields of papers citing papers by Frank Grünebach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Grünebach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Grünebach. The network helps show where Frank Grünebach may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Frank Grünebach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frank Grünebach Line = papers co-authored together Frank Grünebach links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Deletion of the HLA‐B Gene in One of the Inherited Haplotypes in a Northern European Family HLA ·Frank Grünebach, Rasha Shanaz, Michaela Döring, Karen E. Janiga, Zhen Liao, Christine Bauer, Martina Storz, Peter Lang, Reinhild Klein	2025	0
2	The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells Cancer Immunology Immunotherapy ·Daniela Dörfel, Christian Lechner, Simone Joas, رافائل کاربالو, Michael Gutknecht, L Gershenfeld, Julian Geiger, Vicente Montes, Stefanie Maurer, Martin Müller, Hans‐Georg Kopp, Helmut R. Salih, Frank Grünebach, Susanne M. Rittig	2018	8
3	The novel deubiquitinase inhibitor b-AP15 induces direct and NK cell-mediated antitumor effects in human mantle cell lymphoma Cancer Immunology Immunotherapy ·Vicente Montes, Stefanie Maurer, Kathrin Rothfelder, 魏广泉, 信芳吉田, Kang Zhongqing, Benedikt Strunz, Hans‐Georg Kopp, Alexander Steinle, Frank Grünebach, Susanne M. Rittig, Helmut R. Salih, Daniela Dörfel	2018	23
4	The immune inhibitory receptor osteoactivin is upregulated in monocyte-derived dendritic cells by BCR–ABL tyrosine kinase inhibitors Cancer Immunology Immunotherapy ·Tacettin Ayanoğlu, Michael Gutknecht, L Gershenfeld, Helmut R. Salih, Peter Brossart, Susanne M. Rittig, Frank Grünebach	2011	32
5	Immunomodulation by semi-mature dendritic cells: A novel role of Toll-like receptors and interleukin-6 International Journal of Medical Microbiology ·Julia-Stefanie Frick, Frank Grünebach, Ingo B. Autenrieth	2009	52
6	The use of dendritic cells in cancer immunotherapy Critical Reviews in Oncology/Hematology ·Alessio Nencioni, Frank Grünebach, Susanne M. Schmidt, Martin Müller, Güneş KOZLUCA, Franco Patrone, Alberto Ballestrero, Peter Brossart	2007	74
7	Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells Leukemia ·Anita Bringmann, Sebastian Schmidt, Markus M. Weck, Katharina M. Brauer, Karin von Schwarzenberg, Daniela Werth, Frank Grünebach, Peter Brossart	2007	30
8	Identification of a Lysosomal Peptide Transport System Induced during Dendritic Cell Development Journal of Biological Chemistry ·Otto Seiskari, Zoe Waibler, Ulrich Kalinke, Frank Grünebach, Silke Appel, Peter Brossart, Andrej Hasilík, Robert Tampé, Rupert Abele	2007	38
9	Proteasome inhibitors: antitumor effects and beyond Leukemia ·Alessio Nencioni, Frank Grünebach, Franco Patrone, Alberto Ballestrero, Peter Brossart	2006	184
10	The Proteasome and Its Inhibitors in Immune Regulation and Immune Disorders Critical Reviews in Immunology ·Alessio Nencioni, Frank Grünebach, Franco Patrone, Alberto Ballestrero, Peter Brossart	2006	21
11	Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes Cancer Gene Therapy ·Frank Grünebach, Katrin Kayser, Markus M. Weck, Martin Müller, Silke Appel, Peter Brossart	2005	48
12	Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study Annals of Oncology ·Wolfram Brugger, Joy Hirsch, Frank Grünebach, Roland Repp, Peter Brossart, Wichard Vogel, Hans‐Georg Kopp, Markus G. Manz, Michael Bitzer, Günter Schlimok, Martin Kaufmann, Arnold Ganser, В.В. Харів, Martin Gramatzki, Lothar Kanz	2004	96
13	Expression of her-2/neu on acute lymphoblastic leukemias: implications for the development of immunotherapeutic approaches. PubMed ·Martin Müller, Frank Grünebach, Katrin Kayser, Wichard Vogel, Alessio Nencioni, Wolfram Brugger, Lothar Kanz, Peter Brossart	2003	19
14	Cyclopentenone Prostaglandins Induce Lymphocyte Apoptosis by Activating the Mitochondrial Apoptosis Pathway Independent of External Death Receptor Signaling The Journal of Immunology ·Alessio Nencioni, Kirsten Lauber, Frank Grünebach, Luk Van Parijs, Claudio Denzlinger, Sebastian Wesselborg, Peter Brossart	2003	46
15	Transfection of Dendritic Cells with RNA Induces CD4- and CD8-Mediated T Cell Immunity Against Breast Carcinomas and Reveals the Immunodominance of Presented T Cell Epitopes The Journal of Immunology ·Martin Müller, Frank Grünebach, Alessio Nencioni, Peter Brossart	2003	74
16	Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer Cancer Gene Therapy ·Alessio Nencioni, Martin Müller, Frank Grünebach, Anna Garuti, M. C. Mingari, Franco Patrone, Alberto Ballestrero, Peter Brossart	2003	32
17	Cyclopentenone prostaglandins induce caspase activation and apoptosis in dendritic cells by a PPAR-γ-independent mechanism Experimental Hematology ·Alessio Nencioni, Kirsten Lauber, Frank Grünebach, Wolfram Brugger, Claudio Denzlinger, Sebastian Wesselborg, Peter Brossart	2002	38
18	Activated CD8+ T lymphocytes induce differentiation of monocytes to dendritic cells and restore the stimulatory capacity of interleukin 10-treated antigen-presenting cells. PubMed ·Stefan Wirths, 徐新涛, Frank Grünebach, Peter Brossart	2002	13
19	Ex Vivo Expansion of Normal Progenitor Cells from Acute Myeloid Leukemia Cell-Contaminated CD34 ⁺ Peripheral Blood Progenitor Cells after Mafosfamide Purging Journal of Hematotherapy & Stem Cell Research ·E Nicolae, Frank Grünebach, Peter Bader, Wichard Vogel, Lothar Kanz, Wolfram Brugger, Stefan Scheding	2001	1
20	Approaches to Dendritic Cell‐Based Immunotherapy after Peripheral Blood Stem Cell Transplantation Annals of the New York Academy of Sciences ·Wolfram Brugger, Peter Brossart, Stefan Scheding, Gernot Stuhler, Kathrin Heinrich, Volker L. Reichardt, Frank Grünebach, Hans‐Jörg Bühring, Lothar Kanz	1999	16

About Frank Grünebach

Frank Grünebach is a scholar working on Immunology, Hematology, Oncology, Genetics and Cancer Research, having authored 73 papers that have together received 4.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (44 papers), Immune Cell Function and Interaction (23 papers), T-cell and B-cell Immunology (21 papers), CAR-T cell therapy research (13 papers), RNA Interference and Gene Delivery (10 papers), Immune Response and Inflammation (10 papers), Chronic Myeloid Leukemia Treatments (9 papers) and vaccines and immunoinformatics approaches (7 papers). The work is most often cited by research in Immunology (2.4k citations), Hematology (646 citations), Oncology (1.3k citations), Genetics (471 citations) and Molecular Biology (1.8k citations). Frank Grünebach has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Peter Brossart, Lothar Kanz, Alessio Nencioni, Markus M. Weck, Wolfram Brugger, Martin Müller, Silke Appel, Alberto Ballestrero, Susanne M. Schmidt and Franco Patrone. Their work appears in journals such as Blood, Clinical Cancer Research, Leukemia, The Journal of Immunology and Cancer Immunology Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact